v3.26.3
INVESTMENT IN BC THERAPEUTICS INC (Details Narrative) - USD ($)
12 Months Ended
Mar. 18, 2025
Aug. 07, 2024
Dec. 21, 2021
Jul. 31, 2026
Jul. 31, 2025
Feb. 01, 2026
Feb. 01, 2024
Payments to Acquire Investments       $ 377,000 $ 330,000    
Options exercised, shares       301,600      
Options exercised, value       $ 377,000      
Common stock, shares issued       8,708,029 1,883,906    
Common stock, shares outstanding       8,708,029 1,883,906    
BC Therapeutics Inc [Member]              
Equity interest percentage       71.13% 63.10%    
Common stock, shares issued       1,385,600      
Common stock, shares outstanding       1,385,600      
Briacell Therapeutics [Member] | BC Therapeutics Inc [Member]              
Common stock, shares issued       985,600      
Common stock, shares outstanding       985,600      
Share Purchase Agreement [Member] | BC Therapeutics Inc [Member]              
Equity interest percentage     37.50%        
Share Purchase Agreement [Member] | BC Therapeutics Inc [Member] | First Option [Member]              
Equity interest percentage             51.20%
Share Purchase Agreement [Member] | BC Therapeutics Inc [Member]              
Initial loan     $ 300,000        
Share price     $ 1.25        
Fair Value, Option, Changes in Fair Value, Gain (Loss)     $ 76,350        
Exercise price     $ 1.25        
Dividend yield     0.00%        
Risk free interest rate     4.902%        
Volatility     100.00%        
Share Purchase Agreement [Member] | BC Therapeutics Inc [Member] | Two Options [Member]              
Share price     $ 1.25        
Payments to Acquire Investments     $ 225,000        
Share Purchase Agreement [Member] | BC Therapeutics Inc [Member] | Second Option [Member]              
Share price   $ 1.25       $ 1.25  
Options exercised, shares 424,000 20,000          
Share Purchase Agreement [Member] | BC Therapeutics Inc [Member] | Third Option [Member]              
Share price           $ 1.25  
Options exercised, shares       194,400